These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3904801)

  • 61. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
    Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.
    Ghosh AK; Moore M; Harris M
    J Clin Pathol; 1986 Apr; 39(4):428-34. PubMed ID: 3009557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma.
    Rothberg PG; Spandorfer JM; Erisman MD; Staroscik RN; Sears HF; Petersen RO; Astrin SM
    Br J Cancer; 1985 Oct; 52(4):629-32. PubMed ID: 4063140
    [No Abstract]   [Full Text] [Related]  

  • 64. Androgen receptors in colorectal adenomas.
    Stebbings WS; Farthing MJ; Puddefoot JR; Anderson E; Vinson GP; Northover JM; Wood RF
    J Cancer Res Clin Oncol; 1988; 114(2):208-11. PubMed ID: 3350855
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of immunohistochemical results of the ras oncogene product p21 in myelodysplastic syndromes.
    Kalmantis T; Kalmanti M; Vassilaki M; Spandidos DA
    Anticancer Res; 1993; 13(4):1103-6. PubMed ID: 8352532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Expression of Ha-ras oncogene product, p21 in gastric carcinoma].
    Ebihara T; Koyama S; Osuga T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Sep; 84(9):1737-9. PubMed ID: 3323578
    [No Abstract]   [Full Text] [Related]  

  • 68. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice.
    Matarazzo M; Faraggiana T; Donato MF; Paronetto F
    J Exp Pathol; 1987; 3(3):305-15. PubMed ID: 2835467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunohistochemical analysis of normal and mutated ras oncogene p21 expression in human pulmonary and pleural neoplasms.
    Radosevich JA; Gould VE; Ma Y; Lee I; Thor A; Carney WP; Warren WH; Schlom J; Rosen ST
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(6):377-83. PubMed ID: 2567085
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antigenicity of newly established colorectal carcinoma cell lines.
    Durrant LG; Robins RA; Pimm MV; Perkins AC; Armitage NC; Hardcastle JD; Baldwin RW
    Br J Cancer; 1986 Jan; 53(1):37-45. PubMed ID: 3947514
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer: mutant ras proteins and cell transformation.
    Newbold R
    Nature; 1984 Aug 23-29; 310(5979):628-9. PubMed ID: 6382018
    [No Abstract]   [Full Text] [Related]  

  • 72. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Isolation and characterization of a sulfated glycoprotein from a transplantable colorectal adenocarcinoma of rats.
    Munakata H; Yosizawa Z
    Biochim Biophys Acta; 1980 Jun; 623(2):412-7. PubMed ID: 7397223
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ras oncogene expression as a prognostic indicator in rectal adenocarcinoma.
    Michelassi F; Vannucci LE; Montag A; Chappell R; Rodgers J; Block GE
    J Surg Res; 1988 Jul; 45(1):15-20. PubMed ID: 3392989
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunoprecipitation of cell lysates with RAP-5 does not specifically detect ras oncogene product p21.
    Gutheil JC; Mane S; Kapil V; Needleman SW
    Hum Pathol; 1989 Dec; 20(12):1176-80. PubMed ID: 2687155
    [TBL] [Abstract][Full Text] [Related]  

  • 76. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
    Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
    Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship between ras oncogene expression and clinical and pathological features of colonic carcinoma.
    Michelassi F; Grad G; Erroi F; Roncella M; Romagnoli J; Handcock M
    Hepatogastroenterology; 1990 Oct; 37(5):513-6. PubMed ID: 2253930
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of p21ras in fresh primary and metastatic human colorectal tumors.
    Gallick GE; Kurzrock R; Kloetzer WS; Arlinghaus RB; Gutterman JU
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1795-9. PubMed ID: 3885218
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression.
    Cochet O; Kenigsberg M; Delumeau I; Virone-Oddos A; Multon MC; Fridman WH; Schweighoffer F; Teillaud JL; Tocqué B
    Cancer Res; 1998 Mar; 58(6):1170-6. PubMed ID: 9515802
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunohistochemical localization of the epithelial marker MAM-6 in invasive malignancies and highly dysplastic adenomas of the large intestine.
    Zotter S; Lossnitzer A; Hageman PC; Delemarre JF; Hilkens J; Hilgers J
    Lab Invest; 1987 Aug; 57(2):193-9. PubMed ID: 3613527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.